Award recognizes the innovative blend of AI
technology with an empathetic human approach to deliver exceptional
healthcare experiences for members
SEATTLE, March 20,
2024 /PRNewswire/ -- Accolade, Inc.
(Nasdaq: ACCD) today announced it has been named a winner of
the Business Intelligence Group's Artificial Intelligence
Excellence Awards program for its application of Natural Language
Processing. This award recognizes companies leveraging AI
technology to solve real-world problems. Accolade is one of the
only healthcare organizations recognized this year for excellence
in AI.
"We're thrilled to be recognized for our work leveraging AI to
bridge gaps in healthcare and help people live healthier lives,"
said Ardie Sameti, Senior Director
of AI, Automation and Scale at Accolade. "Accolade incorporates the
power of AI and natural language processing in a model trained on
empathetic listening to enhance our Care Team's support of the
millions of members we serve."
Accolade infuses AI into its physician-led
advocacy approach, which puts the member-physician
relationship at the center of every interaction. Accolade partners
with Observe.AI, a live conversation intelligence platform for
contact centers, to improve how it scores call center interactions
for empathetic conversations. In the past, Accolade supervisors
manually evaluated recorded calls, a time-consuming task that only
sampled 2 percent of calls. By integrating Observe.AI, Accolade can
now efficiently analyze 100 percent of member call interactions,
enabling real-time feedback to Care Teams while positively
reinforcing impactful interactions.
"We're proud to embrace the enormous opportunity AI presents in
healthcare while also prioritizing data security and regulatory
compliance to ensure our AI applications are secure and
trustworthy," said Kelli Burns,
Chief Information Security Officer at Accolade. "Our philosophy on
AI innovation is focused on ensuring the most responsible and
ethical use of AI to support our Care Teams as they deliver
life-changing experiences for our members."
Accolade also uses AI to improve member services and digital
health outcomes. This includes automating tasks, such as note
summarization and call routing, to allow Care Teams to be fully
present with members.
"We are truly honored to recognize Accolade with this
prestigious award," stated Maria
Jimenez, Chief Nominations Officer for the Business
Intelligence Group. "The unwavering commitment of their team to
excellence and their innovative AI applications have catapulted
them to this remarkable achievement. Congratulations to the entire
organization!"
About Accolade
Accolade
(Nasdaq: ACCD) is a Personalized
Healthcare company that provides millions of people and their
families with exceptional healthcare experiences so they can live
their healthiest lives. Accolade's employer, health plan, and
consumer solutions combine virtual primary care and mental health,
expert medical opinions, and best-in-class care navigation. These
offerings are built on a platform engineered to care through
predictive engagement of population health needs, proactive care
that improves outcomes and cost savings, and by addressing barriers
to access and continuity of care. Accolade consistently receives
consumer satisfaction ratings of over 90%. For more information,
visit accolade.com. Follow us
on LinkedIn, X,
Instagram and Facebook.
About Business Intelligence Group
www.bintelligence.com
The Business Intelligence Group was founded with the mission of
recognizing true talent and superior performance in the business
world. Unlike other industry award programs, these programs are
judged by business executives having experience and knowledge. The
organization's proprietary and unique scoring system selectively
measures performance across multiple business domains and then
rewards those companies whose achievements stand above those of
their peers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accolade-wins-2024-artificial-intelligence-excellence-award-302094170.html
SOURCE Accolade, Inc.